Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutracreme is a Malaysian biotechnology company specializing in the development and commercialization of high-value nutraceuticals and functional foods. Founded as a spin-off from Universiti Putra Malaysia (UPM) through the UPM-MTDC Symbiosis programme, the company leverages advanced technologies such as Supercritical Fluid Extraction (SFE) and nanotechnology to produce bioactive-rich fractions. Its flagship products, including HSGold and TQGold Nano, focus on the management of chronic conditions like type 2 diabetes and hypercholesterolemia. Nutracreme's research-driven approach aims to enhance the bioavailability and efficacy of natural compounds for global health applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutracreme.